Skip to content

2022 | Topic: Liver tumours

EASL’s response to the European Commission call for evidence on cancer screening

EASL recommends extending the Recommendation to liver cancer for high-risk groups living with chronic liver diseases; these patients are identifiable, have a high risk of liver cancer, and can be offered curative treatment if their liver cancer is diagnosed early. Furthermore, liver cancer detection tools are easily available and affordable.

Back To Top